Metraipolis › archive › dc_7b7342ef09a8

The polyamine inhibitor SAM486A increases the efficacy of adagrasib in non-small cell lung cancer cells harboring KRASG12C mutation — Europe PMC PMID:41715254

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41715254
DOI
10.1186/s40659-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-05T15:37:03.793Z
SHA-256 of the archived text
bc76507172ffac440d4d9e2cbd072427bbb7999b245cc331157922b1684f7ef8
Stable URL of this page
https://metraipolis.com/documento/dc_7b7342ef09a8

How to cite

The polyamine inhibitor SAM486A increases the efficacy of adagrasib in non-small cell lung cancer cells harboring KRASG12C mutation — Europe PMC PMID:41715254 — Europe PMC (en), https://europepmc.org/article/MED/41715254 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7b7342ef09a8 (Metraipolis archive dc_7b7342ef09a8, sha256 bc76507172ffac440d4d9e2cbd072427bbb7999b245cc331157922b1684f7ef8)
BibTeX
@misc{dc7b7342ef09a8,
  title = {The polyamine inhibitor SAM486A increases the efficacy of adagrasib in non-small cell lung cancer cells harboring KRASG12C mutation — Europe PMC PMID:41715254},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41715254},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7b7342ef09a8; sha256 bc76507172ffac440d4d9e2cbd072427bbb7999b245cc331157922b1684f7ef8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41715254. Agents can read the archived copy with the MCP tool read_document.